Abstract
Acute aortic dissection has been among the most lethal entities in the medical literature for centuries. The incidence of acute type A aortic dissection (ATAAD) is 3.5–6 in 100,000 but increases with age and demonstrates a male predominance. Risk factors in older adults include traditional cardiovascular risk factors, while younger patients are more likely to have a connective tissue disorder. Dissection begins as a tear in the intima and if it involves the ascending aorta or arch only it is classified as type A in the Stanford system. The Penn classification is used to assess the degree of organ system malperfusion present in dissection. Clinical presentation as well as biomarkers, such as D-dimer, is used for diagnosis, while confirmation is typically made with imaging including CT, TEE, and MR. Guiding principles of dissection management involve prompt recognition, transfer to intensive care for monitoring, and immediate impulse control – specifically reduction in heart rate, blood pressure, and LV ejection force, or dp/dt. Surgical repair is the mainstay of acute type A aortic dissection treatment, yet the optimal approach to surgery remains unknown. Diverse options include the extent of repair to be attempted (such as arch replacement or root replacement), use of hybrid endovascular modalities (such as frozen elephant trunk technique), cannulation site, and cerebral perfusion strategy. Other acute aortic syndromes include intramural hematoma (blood from the vasa vasorum infiltrates the medial layer) and penetrating atherosclerotic ulcer (plaque erodes through the internal elastic lamina into the media).
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Acute type A ascending aortic dissection
- Penetrating aortic ulcer
- Intramural hematoma
- Total arch repair
- Frozen elephant trunk technique
- Cerebral perfusion
Introduction
Acute aortic dissection has been among the most lethal entities in the medical literature for centuries. In 1760, King George II died suddenly of an aortic dissection. His autopsy report published by Dr. Frank Nicholls in Philosophical Transactions of the Royal Society described injury to the ascending aorta resulting in tamponade [1, 2]. More than two hundred years later, Jonathan Larson, creator of the musical Rent, died of an aortic dissection after misdiagnosis in two separate emergency departments where he presented with chest pain [3]. Despite advances in imaging and surgical technique, acute aortic dissection, especially dissection of the ascending aorta (type A in the Stanford classification), remains a challenge to recognize and treat swiftly.
Epidemiology, Pathophysiology, and Risk Factors
The incidence of acute type A aortic dissection (ATAAD) is 3.5–6 in 100,000 but increases with age [4]. There is a male predominance and the average age of presentation is 48–67 [4]. Given the rarity of dissection, much of the data and analysis comes from registries, including the Internal Registry of Acute Aortic Dissection (IRAD) and German Registry for Acute Aortic Dissection Type A (GERAADA).
The epidemiology of younger patients with ATAAD differs from that of older patients, with more individuals having genetic conditions including Marfan syndrome (FBN1), Loeys-Dietz syndrome (TGFBR1 and TGFBR2), Ehlers-Danlos (COL3A1), Turner syndrome (XO karyotype), and other mutations affecting structural proteins that are not part of known syndromes [5]. In IRAD data, Marfan patients presenting with dissection had a mean age of 35 compared to 64 in non-Marfan patients and comprised 5% of the total group [6]. They were also more likely to present with heart failure, aortic insufficiency, and have a history of aneurysm, but less likely to have hypertension [6]. Bicuspid aortic valves, which are associated with or independent from genetic syndromes, increase risk for dissection due to an acquired deficiency of aortic fibrillin, upregulation of matrix metalloproteinases, and death of smooth muscle [7].
Comorbidities associated with ATAAD include those common to other cardiovascular diseases, including hypertension, smoking, chronic kidney disease, chronic obstructive pulmonary disease, and stroke [4]. Less common associated factors include inflammatory conditions such as Takayasu arteritis, giant cell arteritis, Behçet disease, systemic lupus erythematous, and rheumatoid arthritis [8]. There may be an association between fluoroquinolone antibiotic use and acute aortic dissections. Calcium channel blockers have demonstrated increased aneurysm growth and rupture in Marfan mice and this observation has been observed in Marfan and other heritable aortic aneurysm diseases in humans. Furthermore, data supporting the use of angiotensin receptor blockers (ARBs, such as losartan) in Marfan patients is inconsistent.
Classification
Aortic dissection begins as a tear in the intima which is 1–5 cm in length and starts within 10 cm of the aortic valve (Fig. 9.1) [9].
Anatomic classification follows two main schemes, Stanford and DeBakey. Stanford Type A encompasses any dissection involving the ascending aorta, while Type B involves the descending aorta only. DeBakey classifications include Type I (ascending and descending), Type II (ascending only), and Type III (descending only) (Table 9.1) [4].
Limited intimal tears of the aorta (class 3 dissection) can involve either the ascending or the descending aorta. The clinical course is thought to be similar to that of traditional aortic dissections but may be more difficult to assess on imaging.
Prognostication and surgical approach require understanding the extent of dissection. The Penn classification associates mortality with extent of organ system involvement on presentation (Fig. 9.2) [10]. Dissection without branch vessel involvement or circulatory collapse has an in-hospital mortality of 3.1% (class a), branch vessel malperfusion with ischemia has a mortality of 25.6% (class b), circulatory collapse with or without cardiac involvement has a mortality of 17.6% (class c), and combined b and c has a mortality of 40% (Table 9.2).
Aortic dissection can also be defined temporally, into hyperacute (0–24 hours), acute (2–7 days), subacute (8–30 days), and chronic (>30 days) phases which are associated with increasing mortality from time of symptom onset to management [11].
Diagnosis
Clinical Presentation
Chest pain is present in 79–93% of patients presenting with aortic dissection (Table 9.3) [8, 12]. Hypotension is present in 46% of patients, and it is associated with adverse events including malperfusion, death, ST changes, aortic insufficiency (AI), tamponade, and neurological deficits [13]. Back pain is seen in 47% and hypertension in 36% [8].
Classical physical exam findings in acute aortic dissection include pulse deficit and either narrow or wide pulse pressure. In an examination of IRAD patients with pulse pressure divided into quartiles (narrow, normal, mildly elevated, markedly elevated), narrow pulse pressure was associated with greater hypotension, effusion, and mortality, while widened pressure was associated with a history of hypertension and mesenteric involvement [14]. Contrary to expected results, wider pulse pressure was not associated with a greater degree of AI [14].
Pulse deficit is associated with increased in-hospital mortality neurological deficit, hypotension, shock, and tamponade [15].
Neurological symptoms are seen in up to one third of presenting patients, and can include syncope, seizure, stroke, spinal cord ischemia, hypoxic encephalopathy, and neuropathy [16].
EKG Findings
EKG findings can be used for both diagnosis and prognostication in ATAAD. Coronary involvement can be secondary to actual extension of dissection to the coronaries or can be due to occlusion of ostia by the intimal flap. Classically, dissection is considered when a patient presents with STEMI (ST-elevation myocardial infarction) on EKG, however STE is found in only 4–16% of patients [17, 18]. In a study of 233 patients presenting within 6 hours of symptom onset, 51% had ST-T changes and these patients had a more adverse presentation, including shock, tamponade, severe hypertension, and AI [17].
ST elevation indicates greater likelihood of coronary involvement according to most groups [17, 19, 20]; however one group found no greater coronary involvement when there were ischemic changes [18]. STE in avR specifically is a strong predictor of in-hospital death with an odds ratio of 23.4 [19].
Biomarkers
Biomarkers can be used to favor or exclude a diagnosis of dissection. D-dimer is the degradation product of cross-linked fibrin and is the most widely utilized biomarker in dissection. In a meta-analysis looking at 883 AAD patients versus 1994 non-AAD patients, sensitivity was 95.2% and specificity 60.4% for a value of 500 ng/ml [21]. Short dissection, thrombosed FL, and young age are factors that may cause false negatives [21]. Elevated D-dimer is also an independent risk factor for in-hospital mortality but not long-term mortality [22, 23]. In the IRAD Biomarkers study, ATAAD had a higher D-dimer value than other diagnoses such as myocardial infarction (MI) and pulmonary embolism (PE) [24]. Similar to PE, a level of 500 ng/mL can be used to rule out ATAAD with a NLR of 0.07 in the first day [24].
Troponin T may be an independent risk factor for in-hospital mortality, with a value greater than or equal to 0.042 ng/ml having a sensitivity of 70.8% and specificity of 76.4%. In a study of survivors versus non-survivors of ATAAD, pro-BNP had a mean value of 328 pg/ml in survivors, versus 2240 in non-survivors [25].
Other potential biomarkers which are not yet used clinically include fibrillin [5], matrix metalloproteinases [5], smooth muscle proteins [5, 8], and soluble elastin fragment [8].
Imaging
The purpose of imaging in ATAAD is not only to diagnose, but also to identify features that will be needed in downstream management – namely, site of tear, extent of rupture, and branch involvement [26]. The “classic” finding of widened mediastinum on chest x-ray was observed in only 37.4% of IRAD patients [27] and does not provide sufficient information for surgical planning.
CAT scan (CT) and transesophageal echocardiogram (TEE) are the most commonly used modalities, with CT having the advantage of wide availability and operator-independence [26]. During 17 years of data assessed by IRAD, CT use increased from 46% to 73% [12]. One downside to CT is that aortic flow may cause imaging artifact and be confused with a false lumen [26], but this can be minimized by using ECG-gating [28]. Features to look for include a double barrel lumen, entry tear, dilated aorta, and displaced aortic calcification [28] (Fig. 9.3). In one retrospective study, the presence of a pericardial effusion and dilated ascending aorta were predictive of tear in the ascending aorta, whereas a non-thrombosed false lumen in the descending aorta predicted presence of a tear distal to the arch [29]. CT has a sensitivity and specificity of nearly 100% [30].
Transthoracic echocardiogram (TTE) (Fig. 9.4), while useful for assessing aortic insufficiency, dilatation, and effusion, has a low negative predictive value [31] and a sensitivity and specificity of 87% and 91%, respectively [28]. TEE (Fig. 9.5) is a mobile imaging modality that has strength in assessing effusion size and coronary involvement, but is less able to identify branch vessel involvement [26]. The test is operator-dependent, semi-invasive [26], and susceptible to motion artifact from reverberations off the anterior wall of the left atrium [31]. The presence of a patent false lumen on TEE is a poor prognostic factor [32]. Sensitivity for Type A dissection has been calculated at 96.8% and specificity 100% [28].
MR (Fig. 9.6) has a sensitivity of 95–100% [30] but is less widely available than other modalities, takes longer, and compromises access to patients with a life-threatening condition [33].
The responsibility of diagnosis in ATAAD typically falls on the emergency department. In a recent retrospective review of ATAAD cases, focused point-of-care cardiac ultrasound by an emergency department physician had a median diagnosis of 80 minutes versus 226 minutes in those who did not received focused ultrasound [34].
Diagnostic Error
Recognition of ATAAD in the face of more common chest pain syndromes is a priority in reducing mortality. Incorrect anchoring onto alternate diagnoses such as acute coronary syndrome may not only delay diagnosis, but may lead to harmful management such as use of antiplatelet or antithrombotic agents [35]. In one review of 127 patients with type A dissection, inappropriate initial diagnosis was made in 37% of cases and the median time to final diagnosis was 1.5 hours [36]. Diagnosis was further delayed in patients who had walked in and had coronary malperfusion [36].
Others have found much longer median time to diagnosis of 3–4.3 hours [37, 38]. IRAD data found that risk factors for delayed recognition include female sex, atypical pain, lack of hypotension, presentation to a non-tertiary facility, and presence of fever [37].
Diagnostic pitfalls may also be related to radiology interpretation. Chest x-ray is normal in 20–37.4% of patients [27, 39] and abnormalities on CT may be subtle, including displacement of aortic calcification or increased intimal attenuation due to thrombosis of the false lumen [39].
Management of Acute Type A Aortic Dissection
Type A aortic dissection is highly lethal, with mortality reaching 1–2% for every hour without surgical intervention [40, 41]. The guiding principles of acute type A aortic dissection management involve prompt recognition, transfer to intensive care for monitoring, and immediate impulse control – specifically reduction in heart rate, blood pressure, and LV ejection force, or dp/dt [40]. While patients are being evaluated for surgical intervention, or if they are deemed non-operable candidates, impulse control is achieved through the use of vasodilators, beta blockers, and calcium channel blockers. Arterial vasodilators, such as hydralazine, are relatively contraindicated as they may cause reflex tachycardia [42]. Adequate volume resuscitation and pain control should also be used to maintain a systolic blood pressure goal of 100–120 mm Hg [40].
Medical-Only Approach
Although type A aortic dissection is typically managed by immediate surgery, medical management alone is sometimes indicated. Indications for medical management alone may include stroke, severe comorbidities, prior aortic valve replacement (AVR), and late presentation more than 48–72 hours after dissection [40].
Heparinization of patients for bypass and the return of blood flow to infarcted areas of brain tissue in completed stroke are risk factors for hemorrhagic conversion [40, 43]. Therefore when stroke has been completed, risks of surgery may outweigh benefits, though the risk may be acceptable in evolving stroke [40]. A short series of four patients found that intentional delay in stroke patients before aortic surgery had beneficial outcomes [44]. On the other hand, recent data evaluating a more aggressive approach to patients with neurological injury did not show any cases of hemorrhagic conversion after anticoagulation for bypass [45].
Advanced age also increases risk for death, and outcomes in geriatric patients are described later. Age alone is not an absolute contraindication to surgery. Late presentation patients have survived the most dangerous window of dissection and can more safely undergo scheduled surgery. Previous AVR also allows delayed time until surgery, given lower likelihood that the patient will develop severe aortic insufficiency, protection of the right coronary artery from the prior graft placement, and lower risk of aortic rupture due to periaortic adhesions [40].
Centofanti et al., in a retrospective review, developed a risk equation to determine if operative benefit outweighed risk. Risk factors for mortality included age, coma, renal failure, shock, and reoperation. They found that in patients with mortality less than or equal to 58%, surgery was always beneficial [46].
Severe neurological deficit (ND), especially coma, has historically been a relative contraindication to surgery. Surgeons have become increasingly liberal when operating on patients with neurological deficits and outcomes may be improving in this group. At one center, 8-year experience with a range of ND from comatose state to focal deficit underwent surgery, with over 50% of patients showing complete recovery. An elevated preoperative modified Rankin scale score was associated with persistent deficits [47], but even some patients with comatose state showed partial or full recovery. Notably, few comatose patients underwent surgery in this group [47]. In another recent single-center study of 24 comatose patients who underwent surgery, in-hospital mortality was similar to that of non-comatose patients, and long-term mortality was 60.3% at 5 years and 48.3% at 10 years [45]. Furthermore, Di Eusanio and colleagues published IRAD data showing that medical management alone was performed in 33.3% of coma and 24.1% of cerebrovascular accident (CVA) patients, and higher in-hospital mortality was observed in both groups compared to patients without ND. However, in those patients with ND who underwent surgical management, mortality was significantly less than in the medical management group. CVA patients had 76.2% mortality in the medical vs. 27% in the surgical group, while the coma patients strikingly had 100% mortality in the medical group vs. 44.4% in the surgical group [48]. Therefore, recent trends in management of severe neurological injury patients may begin to favor aggressive management.
Surgical Approach
Surgical repair is the mainstay of acute type A aortic dissection treatment, yet the optimal approach to surgery remains unknown. Diverse options include the extent of repair to be attempted, use of hybrid endovascular modalities, cannulation site, and cerebral perfusion strategy (Fig. 9.7).
Survival in type A aortic dissection is improved when performed by specialized aortic surgeons, rather than general cardiac surgeons. In a German study of 162 consecutive patients who underwent ATAAD surgery with a dedicated aortic team compared to a general cardiac surgery team, in-hospital mortality was 4% versus 21.8%, though surgical techniques were variable among the groups [49]. Other environmental factors which may improve outcomes include the development of an aortic dissection protocol [50] and performance of surgery at a teaching hospital [51] or a high volume center [51].
Extent of Repair and Risk of Reoperation
The over riding goal of aortic repair during type A dissection is to leave the operating room with a living patient. Repair typically involves excision of the primary entry tear in order to avoid extension of the dissection, prevent aortic rupture, and restore flow to the true lumen while obliterating the false lumen [41, 52]. As surgical techniques and outcomes have improved, the extent of repair has become open to debate, with the hope of not simply stabilizing the patient but also reducing the need for downstream intervention. Surgery may involve replacement of ascending aorta with a synthetic vascular graft and proximal arch repair only, versus extensive repair including the total arch, descending aorta, and/or root.
While proximal reoperations are most related to the degree of postoperative aortic insufficiency [53], distal reoperations are most often due to distal aneurysmal disease. At the Cleveland Clinic, 305 type A patients required 429 distal interventions during 3.8 years follow-up. The study’s authors argued for more extensive repair in appropriate patients at the time of initial intervention [54]. Others have found that the descending aorta diameter grows at a rate of 1 mm/year after repair, with a risk of reoperation of 16% at 10 years [55]. In addition to distal aortic diameter, residual patency of the false lumen is predictive of late outcomes [55, 56].
Total Arch Replacement
Total arch replacement (TAR) , as compared to hemiarch repair, is indicated in aneurysmal disease greater than 5 cm, arch rupture, and complex arch tear [57]. In studies comparing TAR outcomes to limited proximal repair, there was similar earlier mortality [57, 58], stroke [57], and reintervention rate [59, 60]. In most [61, 62] but not all [60, 63] studies, TAR led to increased thrombosis of the false lumen compared to hemiarch repair. In GERAADA, immediate postoperative complications such as bleeding were higher in TAR, but 30-day outcomes showed no difference compared to conservative arch repair [64]. However, one group of 188 patients, 44 with TAR, found greater risk of death and permanent neurologic injury with TAR [60].
Arch tears are uncommon and have not been extensively studied. In one center’s study of 106 patients with ATAAD, 16 had arch tears and preoperative tamponade was a predictor of mortality. The rate of stroke was 6.6% and that of temporary neurologic dysfunction was 20% [65]. In another group of patients with 88 arch tears, in-hospital mortality was significantly higher for those undergoing TAR, and the authors recommended performing hemiarch repair only if the tear was limited to the lesser curvature [66].
Frozen Elephant Trunk Technique
Attempts to treat and prevent future distal aneurysmal disease at the time of ATAAD surgery has led to the increasing prevalence of graft placement in the thoracic aorta. The classic elephant trunk technique was first described by Borst in 1983 in which the arch replacement prosthesis is connected to an “elephant-trunk” piece which reaches into the distal aorta and allows a landing site for future repairs [67]. The frozen elephant trunk technique is a newer method that uses an endovascular stent-graft connected to the arch graft, allowing a single-stage distal aortic repair [41, 67].
FET has enjoyed mainly positive findings, leading to a surge in its popularity. It is often described as the “new standard” for ATAAD surgery [68]. Numerous centers have found that FET either decreases or has low rates of reintervention on the distal aorta [62, 69,70,71]. In one analysis of 197 patients, thrombosis of the false lumen was found in all of the patients in the TAR + FET group and only 24.6% of the limited repair group (p < 0.001) [62].
Two meta-analyses have assessed FET outcomes. An analysis of eleven observational studies including 881 patients found acceptable in-hospital mortality at 8%, neurological outcomes of stroke 4%, and spinal cord injury (SCI) of 3% [72]. While some centers have found that FET decreases mortality [73], others have found similar in-hospital mortality to the classic ET [62, 74]. In another analysis of nine studies looking at 1872 patients comparing proximal aortic repair (ascending aorta repair +/− hemiarch) and extensive aortic repair (replacement of ascending aorta and aortic arch + elephant trunk implantation in descending aorta), hemiarch replacement had a lower early mortality than TAR. Proximal repair, however, was associated with a higher incidence of long-term aortic events such as reoperation. The long-term mortality was similar in both approaches [75].
Concerns about FET revolve around feared neurological complications, including SCI. FET requires longer bypass and surgical times, and the placement of endovascular stents increases the risk of SCI. While conventional elephant trunk surgery has a low rate of SCI, FET has ranged from 4% to 22% in patients undergoing acute repair [74, 76,77,78]. Additionally, a comparison of hemiarch + FET compared to TAR + FET showed similar mortality but fewer transient neurologic deficits in the hemiarch group [79].
Root
Root repair and valve replacement are another source of debate in the extent of surgery performed for acute dissection. Options for repair include a Bentall procedure with biological or mechanical aortic root replacement (ARR), or valve-sparing surgery such as the David procedure. In patients for whom the root is involved, a root-sparing technique had lower mortality compared to valve replacement (1.9 vs. 12.5%) in a group of 86 patients [80] but was similar in numerous other studies [81,82,83,84,85,86,87]. The greatest benefit for ARR is in patients with connective tissue disease [82, 87,88,89], aneurysmal disease [88, 90], younger age [89], and intimal tears of the sinus segment [88, 91].
Bicuspid and Marfan Patients
Acute type A aortic dissection occurs approximately 20 years earlier in patients with Marfan Syndrome than without, and repair for ATAAD accounts for 16–35% of aortic procedures performed in this population. Though in-hospital mortality for these patients was low in a retrospective study of repair for AATAD in Marfan Syndrome at tertiary care centers in the United States and Europe, they recommend root replacement in these patients [92].
Bicuspid aortic valve (BAV) patients who present with type A dissection are younger, have more aortic insufficiency, and have larger ascending aortic diameters than do tricuspid valve patients. Root repair is required six times more often in BAV patients [93].
Temperature and Cerebral Perfusion Technique
The German Registry for Acute Aortic Dissection Type A found that hypothermic circulatory arrest alone was appropriate if the repair could take less than 30 minutes, but once it exceeded this time limit, mortality increased three-fold. This suggests that a cerebral perfusion strategy should be implemented during more complex procedures [94].
Retrograde cerebral perfusion was one of the first adjunctive techniques introduced [95], which utilized perfusion via the SVC but could result in cerebral edema [96]. The more common adjunct now used is selective antegrade cerebral perfusion (SACP) , which can be unilateral or bilateral, and involves cannulation of the head and neck vessels [94]. Antegrade technique has shown similar [97, 98] or more favorable [99, 100] outcomes compared to retrograde perfusion.
Recently, moderate levels of hypothermia >24C have been used successfully along with antegrade or retrograde cerebral perfusion methods [101]. One study of patients who underwent repair at Emory from 2004 to 2014 found similar outcomes in patients who underwent deep and moderate hypothermic circulatory arrest, with no significant difference in stroke or dialysis-dependent renal failure [102]. Moderate hypothermia may allow for a decrease in bypass time as compared to that with deep hypothermia protocols [103]. Another recent study of ATAAD repair found that there was no additional benefit of using deep hypothermic cardiac arrest (DHCA) compared to moderate hypothermic cardiac arrest (MHCA) when SACP was used [102].
Cannulation Strategy
Arterial cannulation is necessary for cardiopulmonary bypass during ATAAD surgery and can be performed in a retrograde (femoral) or antegrade (axillary, innominate, transatrial, and transapical direct cannulation of the aorta) fashion [104]. In two meta-analyses, axillary cannulation showed lower early mortality and neurological dysfunction than did femoral cannulation [105, 106]. Similarly, a best evidence topic found that femoral artery cannulation mortality and stroke occurred at rates of 6.5–40% and 3–17%, compared to axillary rates of 3–8.6% and 1.75–4% [107]. The main downside to femoral access is that retrograde flow is thought to cause reverse embolization through pressure in an atheromatous descending aorta [105].
While axillary cannulation takes longer than femoral access to establish [105], central cannulation can be quickly achieved in order to establish circulatory arrest [108,109,110]. Some groups have found that stroke and overall mortality were lower in transatrial cannulation compared to femoral [104]. Others found no mortality or stroke reduction when comparing central cannulation to femoral cannulation [108, 109, 111]. Outcomes such as respiratory failure have mixed data, with some showing more respiratory failure with central cannulation [112], while others show shorter intubation times [113].
Outcomes
Mortality
In-hospital and long-term mortality for ATAAD remain elevated but have been improving over the last few decades [114, 115]. In type A patients who underwent surgical repair in the National Inpatient Sample, mortality decreased from 20.5% in 2003 to 14.8% in 2012 [115]. Others have found early mortality rates of 16.9–25.7% [116, 117], with predictors of in-hospital mortality including comatose state, number of malperfused organs, older age, and need for cardiopulmonary resuscitation [117, 118].
Prior cardiac surgery is also associated with significantly higher in-hospital mortality compared to patients without prior cardiac surgery, with rates varying from one third [119], to double [120], or almost triple [121] those without prior cardiac surgery.
In a multicenter Italian study spanning 33 years of follow-up, survival was 95.3% at 5 years, 92.8% at 10 years, and 52.8 at 20 years [116].
Malperfusion: Complicated and Uncomplicated Dissection
Malperfusion is a dreaded complication that can occur preoperatively, intraoperatively, or postoperatively and is associated with both perioperative and long-term mortality. Perfusion defects result when aortic side branches are compromised and can be classified as static or dynamic. Dynamic refers to malperfusion that occurs from the intimal flap decreasing blood flow to vital organ systems; restoring blood flow via the true lumen will therefore reinstate perfusion [122]. Static malperfusion syndromes (MPS) are the result of stenosis, thrombosis, or dissected artery [52]. Approximately one third of patients with ATAAD present with a malperfusion syndrome [123,124,125,126].
In a study of GERAADA patients (n = 2137), there was a linear correlation between the number of malperfused organs and increase of mortality of 10% [127]. Given this dramatic worsening of outcome with malperfusion, the authors argued for classifying dissection as either complicated or uncomplicated based on the presence of malperfusion. In the postoperative period, cerebral malperfusion was seen in 6.8% of patients, renal 6.8%, visceral 6.8%, peripheral 3.3%, coronary in 1.9%, and spinal 1.1%.
Complicated dissection is associated with worse survival, with patients at the University of Michigan showing median survival of 54 months if complicated versus 96 months if uncomplicated [122]. Similarly, Olsson et al. found that Penn class at presentation corresponds to mortality [128]. Other poor outcomes of complicated dissection include coma, MI, sepsis, delirium, renal failure [129], and prolonged ICU stay [124]. One look at quality of life in patients who presented with MPS found no difference from non-MPS patients, except in the case of CNS malperfusion [130].
Mesenteric ischemia has high morbidity and mortality, with 3.7% of IRAD patients showing mesenteric malperfusion on presentation. These patients showed significantly greater mortality than those without mesenteric malperfusion (62.3% vs. 23.8%) and were more likely to show malperfusion in additional organ systems including coma and renal failure [131]. Others have shown mortality that is as high as 75% [124]. Some case reports argue for addressing the mesenteric ischemia first during repair [132, 133].
In 502 patients from the Emilia-Romagna Regional Registry, 20.5% of patients presented with malperfusion, and had higher in-hospital mortality than did the non-malperfusion group (43.7% vs. 15%, p = 0.001). Like in the GERAADA data, multiple organ systems were associated with worse survival – single-organ malperfusion had a mortality rate of 34.7%, two systems 61.9%, and more than two 85.7% [123].
Patel et al. looked at delaying aortic repair in patients who have MPS, given a lower likelihood of surviving aortic repair. They found that patients who did survive to the aortic repair had similar mortality to those with uncomplicated dissection [125]. In a study that combined both type A and B dissections, patients with MPS had triple the operative mortality compared to uncomplicated patients [134].
Shiya et al. proposed techniques for addressing complicated dissection by system – CABG for coronary malperfusion, SCP for cerebral malperfusion, CA and SMA bypass in visceral malperfusion, and fem-fem bypass in unilateral lower extremity malperfusion [135]. Coronary malperfusion is found in 6–15% [41, 136, 137] of patients and most often compromises the right coronary artery [41].
Independent predictors for both neurologic injury and postoperative renal failure include age, prolonged cross-clamping time, and longer cerebral perfusion times. Renal failure is also predicted by preexisting renal impairment [138].
Age
Whether or not to perform surgery in older patients, who frequently have more comorbidities than younger counterparts, has been the source of debate. In patients of all ages, hemodynamic instability is predictive of poor outcomes [139].
While greater extent of repair has overall become the trend in ATAAD surgery, many centers have focused on limited repair to just the ascending aorta or hemiarch to allow for shorter surgical times in octogenarians [140,141,142,143]. Extension of the dissection into the supraaortic vessels and down to the abdominal aorta actually decreases with age [144], however if arch surgery is needed, it may be a predictor of mortality [145]. The elderly may have a non-significant trend toward more tamponade and intubation at the time of surgery [146]. A “less invasive quick replacement” technique involving no cerebral protection strategy and rapid rewarming shortened surgical times [147] and decreased mortality [148].
GERAADA found that septuagenarians had an early mortality rate of 15.8%, which was similar to the entire registry’s 30-day mortality of 16.9%. Octogenarians, however, had more than double the early mortality at 34.9% [149]. Most others have found similar high perioperative mortality [142, 145, 150,151,152] though a few reports have found comparable in-hospital mortality to younger patients [153,154,155]. In IRAD, patients from 70 up to 80 had significantly decreased in-hospital mortality with surgical compared to medical management, whereas 80–90 year olds had decreased mortality with surgery (37.9% vs. 55.2%), but it failed to reach significance [156].
Discrepancies in mortality are also seen in longer term outcomes in the elderly. One year survival is 53.3–82% compared to generally more than 90% in younger patients, and five-year mortality 42.6–76% [140, 142, 157, 158]. Successful ATAAD surgery has been performed in a nonagenarian [159].
Generally, surgical treatment in the elderly is recommended given higher but acceptable perioperative mortality compared to medical management only [160]. One study found higher rates of neurological complications in the elderly which trended down with SACP [161] and others have found no significant difference in temporary neurologic dysfunction when SACP was used [162]. However, further study is needed to determine long-term outcomes, with some centers finding a decreased ability to live independently [158] while others found higher emotional well-being scores compared to younger patients [154].
On a study of root replacement in octogenarians, only some of whom had type A dissection, in-hospital mortality was similar to that in younger patients but there was greater postoperative atrial fibrillation [163].
Young patients between ages twenty and forty have lower mortality, ranging from 11% to 14% at 30 days, with mortality rising with age [144, 164]. Etiology of dissection in the young includes bicuspid aortic valve, connective tissue disease, cocaine use, and severe hypertension [164] and reoperations at the root were needed in 40% of patients [164]. These patients typically have larger aortic diameters than older patients [165]. Neurological outcomes in GERAADA did not differ among age groups [144].
Race
Little data is available on outcomes by race in acute aortic dissection. IRAD compared black and white patients, and found that the black cohort had significantly more HTN, DM, and cocaine use. They more often presented with abdominal pain and LVH on echocardiogram. Despite differences in presentation and risk factors, in-hospital and 3-year mortality between groups were similar [166].
Sex
Presenting characteristics for men and women differ in ATAAD, but whether there is a true difference in outcomes is unknown. Women experience type A dissection less frequently than do men, and therefore, fewer women are represented in registries and trial data. In 2004, IRAD included 32.1% women and showed that women presented for ATAAD at an older age than did men [167], with additional studies showing the age range for men 58–59.7 and women 67–71.5 [168, 169]. Women were more likely to present with coma, altered mental status, hypotension, and tamponade [167].
Early data showed that women had higher in-hospital mortality even after adjusting for age [167], however more recent data showed similar early and late mortality between sexes [168, 169]. One trial showed different findings, with more neurologic deficits in men and greater mortality in women [170]. Interestingly, surgeons’ approaches to women may differ than approaches to men in surgical technique. In an analysis where women were an average age of 71.5 compared to 59.7 in men, women had less extensive surgery (less TAR and root surgery) and shorter surgical times. The difference in approach may be attributed to the older age at presentation of women, a finding that warrants further investigation [171].
Women are also less likely to be discharged on beta blockers than men, though not significantly [168].
The pathophysiology that explains sex-based differences is unclear. A study of aortic geometry throughout life in patients without aortic pathology showed that women have smaller aortic dimensions at younger ages, but their aortic dimensions increase at a faster rate than men’s rates [172]. When indexed by body-surface area (BSA), women’s ascending aortic length increased by 2.9% per decade compared to 2.5% in men, and aortic diameter increased 3.4% in women compared to 2.6% in men. At older ages, women had higher BSA-adjusted aortic diameters than men [172].
Pregnancy
Type A dissection is rare in pregnancy but accounts for more than three-quarters of dissections that occurs in pregnant patients and has a maternal mortality of 21% [173]. The pathophysiology of pregnancy, including increased estrogen binding to aortic wall estrogen receptors and increase in cardiac output, elevates wall stress and can bring about dissection in those already at risk [173]. The third trimester, when intravascular volume has increased and hemodynamic effects of pregnancy are greatest, is when most dissections occur [174]. Marfan syndrome is associated with more than half the associated cases in the literature [173]. In a review of 75 cases of dissection in pregnancy, fetal mortality was reduced if C-section was performed concomitantly with aortic repair [173]. Current recommendations for dissection follow general guidance of cardiac surgery in pregnancy, suggesting maintaining a MAP > 70 mmHg and avoiding deep hypothermic arrest [174].
LV Function
While mortality is the major outcome of concern after type A dissection repair, long-term outcomes such as LV function have been studied. In a study of 97 patients who underwent valve-sparing aorta replacement (VSAR), supracoronary ascending aorta replacement (SCAR), and aortic valve and aorta replacement (AVAR), aortic regurgitation was greater in those who underwent only partial repairs compared to AVAR. Although immediate postoperative LV function was similar among surgical techniques, the SCAR group showed late adverse LV remodeling [175].
Iatrogenic Dissection
Iatrogenic aortic dissection is an uncommon but real complication during coronary procedures and cardiac surgery. It occurs in <0.1% of patients who undergo coronary angiography(176–178), most often when trying to engage a coronary artery, and generally has favorable outcomes despite the use of antithrombotics and antiplatelet agents [176]. Retrograde dissections typically self-sealed, while anterograde with an entry point at a coronary artery could be sealed with a stent [176]. The incidence of dissection during cardiac surgery is more common, ranging from 0.06% to 0.29% of cases [177,178,179] with mortality as high as 40% [179]. One group suggested that intraoperative TEE may be responsible for their observed decrease in iatrogenic dissection over time [179].
Follow-Up
In patients who survive ATAAD, serial imaging is recommended at 1 month, 3 months, 6 months, 12 months, and annually if no concerning features are found [5].
Hypertension control is the main parameter monitored in the follow-up period, with lower blood pressure and beta-blocker use associated with freedom from reoperation [180]. In one analysis of ATAAD patients, freedom from reoperation was 99%, 82%, and 79% at 1, 5, and 10 years respectively [181]. Proximal risk factors for reoperation included the use of glue and root preservation, while distal reoperation was more likely with a patent false lumen [181]. Others found that a patent false lumen was associated with significantly greater growth rate of the aorta, but this growth did not translate into higher distal reoperation rate [182]. Another group found that late reoperation wad predicted by a non-resected primary tear, Marfan syndrome, lack of beta-blocker use, and persistent hypertension [183].
Limited data is available on quality of life and changes in lifestyle after dissection. One study of survivors, which acknowledges recall bias, surveyed 82 out of 197 patients, over half of whom had ATAAD, a median of 7 years after discharge [184]. More patients said that they exercised than pre-dissection, which corresponded to lower blood pressures than those who did not exercise. While before dissection 38% of patients lifted for their occupation, only 3% (one patient) lifted afterwards [184]. Seventy-six percent of patients felt that dissection had negatively impacted their lives, due to burden of doctor visits, number of medications, activity limitations, fear, and impact on sex life. About one third self-reported depression and one third anxiety [184].
Intramural Hematoma (IMH)
Epidemiology and Presentation
IMH is an acute aortic syndrome that occurs when blood from the vasa vasorum infiltrates the medial layer [185], but there is no intimal tear and the hemorrhage does not communicate with the lumen (Fig. 9.8) [5]. Blood pools close to the adventitial layer [186] which increases the risk of tamponade [187]. IMH is classified into type A and type B like dissection, with type A having greater mortality [4] but type B comprising the majority (50–85%) of cases [187, 188]. Approximately 16–47% of patients with IMH progress to full dissection [4]. IMH patients tend to be older [189, 190], have more hypertension [191, 192], and have more pericardial effusion [190] and tamponade [191] than do classic dissection patients but are less likely to present with malperfusion [191,192,193], aortic insufficiency [189, 191, 193], or have Marfan syndrome [194]. Like dissection patients, IMH patients typically present with chest pain, but they are more likely to have a normal EKG [189].
Interestingly, IMH is more common in Asia where one third to one fourth of all type A dissections are the result of IMH [188].
Diagnosis, Treatment, and Outcomes
CT, MRI, and TEE are all used to diagnose IMH [195]. On noncontrast CT, IMH appears as an area of high attenuation, but it can be easily missed on first imaging due to appearing like a thrombosed false lumen [31]. IMH should result in wall thickness > 7 mm and appear crescent-shaped [187]. MRI is particularly sensitive in assessing abnormalities of the vascular wall [187].
Medical versus surgical management is controversial in type A IMH, with Western countries favoring surgical management. There are mixed outcomes looking at medical management in Asia. In a Korean registry of 165 patients, there was no significant difference in in-hospital or two-year mortality between medically and surgically managed patients [196]. A review of 328 cases of type A IMH in twelve studies also concluded that there was no significant difference in early mortality between medical and surgical approaches, however up to 40% of patients progressed to dissection or aneurysm downstream [197]. A best evidence topic, though, found that there was lower mortality in type A IMH with a surgical approach [198]. In a group of 179 patients, the medical management group had higher mortality including more emergent surgery for pericardial tamponade [199]. Others found that up to 30% of patients progressed to true dissection when managed medically [200]. When patients are medically managed, conversion to true dissection is not always immediate, and may actually be more common after 8 days [201].
Aortic diameter > 50 mm [200, 202] or 55 mm [203] and hematoma thickness > 16 mm are predictive of adverse aortic events [203]. In a group of patients with both type A IMH and dissection, a ratio of false lumen thickness/aortic diameter > 0.98 was predictive of adverse aortic outcomes [204].
Penetrating Atherosclerotic Ulcer (PAU)
PAU is the least common acute aortic syndrome, comprising less than 10% of cases [26, 205]. PAU occurs when an atherosclerotic plaque erodes through the internal elastic lamina into the media (Fig. 9.9) [8]. It was first described as a separate entity from dissection by Stanson et al. in 1986 [206]. On pathologic examination, plaque erosion leads to medial hemorrhage and pseudoaneurysm of the aortic wall, which is distinct from cystic medial necrosis seen in dissection [207]. PAU is more likely than type A dissection to rupture the aorta, with 32–42% resulting in rupture [5, 208]. PAU may also progress to dissection [209]. The ulcers vary in depth from 4 to 30 mm and in diameter from 2 to 25 mm [209].
PAU is generally a disease of the descending thoracic aorta, occasionally the arch, and exceedingly rare to find in the ascending aorta though case reports are available [210,211,212,213]. The entity is described in more detail in the chapter on descending aortic diseases. In one study of 328 PAU detected on CTA, 27 occurred in the arch and none in the ascending aorta [205]. In another series, 2 out of 15 ulcers were in the ascending aorta [214]. Risk factors for PAU include comorbidities that contribute to atherosclerosis, including older age [214, 215], male sex [202], and hypertension [202].
Type A PAU are generally repaired surgically [215], though there is debate about how best to manage these ulcers in the descending aorta when their symptomatology varies from incidental finding to aortic rupture [202]. Increasingly, endovascular repair is being used for these lesions in the descending thoracic aorta [209].
Abbreviations
- AI:
-
Aortic insufficiency
- ARR:
-
Aortic root replacement
- ATAAD:
-
Acute type A aortic dissection
- AVAR:
-
Aortic valve and aorta replacement
- AVR:
-
Aortic valve replacement
- BAV:
-
Bicuspid aortic valve
- CVA:
-
Cerebrovascular accident
- DHCA:
-
Deep hypothermic cardiac arrest
- FET:
-
Frozen elephant trunk technique
- GERAADA:
-
German Registry for Acute Aortic Dissection Type A
- IRAD:
-
Internal Registry of Acute Aortic Dissection
- MHCA:
-
Moderate hypothermic cardiac arrest
- MI:
-
Myocardial infarction
- MPS:
-
Malperfusion syndrome
- ND:
-
Neurologic deficit
- PE:
-
Pulmonary embolism
- SACP:
-
Selective antegrade cerebral perfusion
- SCAR:
-
Supracoronary ascending aorta replacement
- SCI:
-
Spinal cord injury
- STEMI:
-
ST-elevation myocardial infarction
- TAR:
-
Total arch replacement
- TEE:
-
Transesophageal echocardiogram
- TTE:
-
Transthoracic echocardiogram
- VSAR:
-
Valve-sparing aorta replacement
References
Criado FJ. Aortic dissection: a 250-year perspective. Tex Heart Inst J. 2011;38(6):694–700.
Nicholls F. Observations concerning the Body of His Late Majesty, October 26, 1760, by Frank Nicholls, MDFRS Physician to His Late Majesty. Philos Trans. 1761;52:265–75.
Rosenthal E. 2 Hospitals Fined in Wake of Death of ‘Rent’ Creator. The New York Times. 1996.
Mussa FF, Horton JD, Moridzadeh R, Nicholson J, Trimarchi S, Eagle KA. Acute aortic dissection and intramural hematoma: a systematic review. JAMA. 2016;316(7):754–63.
Clough RE, Nienaber CA. Management of acute aortic syndrome. Nat Rev Cardiol. 2015;12(2):103–14.
Januzzi JL, Marayati F, Mehta RH, Cooper JV, O’Gara PT, Sechtem U, et al. Comparison of aortic dissection in patients with and without Marfan’s syndrome (results from the International Registry of Aortic Dissection). Am J Cardiol. 2004;94(3):400–2.
Golledge J, Eagle KA. Acute aortic dissection. Lancet. 2008;372(9632):55–66.
Bonaca MP, O’Gara PT. Diagnosis and management of acute aortic syndromes: dissection, intramural hematoma, and penetrating aortic ulcer. Curr Cardiol Rep. 2014;16(10):536.
Dieter RS, Kalya A, Pacanowski JP Jr, Migrino R, Gaines TE, Dieter RA 3rd. Acute aortic syndromes: aortic dissections, penetrating aortic ulcers and intramural aortic hematomas. Expert Rev Cardiovasc Ther. 2005;3(3):423–31.
Augoustides JG, Szeto WY, Desai ND, Pochettino A, Cheung AT, Savino JS, et al. Classification of acute type A dissection: focus on clinical presentation and extent. Eur J Cardiothorac Surg. 2011;39(4):519–22.
Booher AM, Isselbacher EM, Nienaber CA, Trimarchi S, Evangelista A, Montgomery DG, et al. The IRAD classification system for characterizing survival after aortic dissection. Am J Med. 2013;126(8):730 e19–24.
Pape LA, Awais M, Woznicki EM, Suzuki T, Trimarchi S, Evangelista A, et al. Presentation, diagnosis, and outcomes of acute aortic dissection: 17-year trends from the international registry of acute aortic dissection. J Am Coll Cardiol. 2015;66(4):350–8.
Tsai TT, Bossone E, Isselbacher EM, Nienaber CA, Evangelista A, Fang J, et al. Clinical characteristics of hypotension in patients with acute aortic dissection. Am J Cardiol. 2005;95(1):48–52.
Hoff E, Eagle T, Pyeritz RE, Ehrlich M, Voehringer M, Bossone E, et al. Pulse pressure and type A acute aortic dissection in-hospital outcomes (from the International Registry of Acute Aortic Dissection). Am J Cardiol. 2014;113(7):1255–9.
Bossone E, Rampoldi V, Nienaber CA, Trimarchi S, Ballotta A, Cooper JV, et al. Usefulness of pulse deficit to predict in-hospital complications and mortality in patients with acute type A aortic dissection. Am J Cardiol. 2002;89(7):851–5.
Gaul C, Dietrich W, Friedrich I, Sirch J, Erbguth FJ. Neurological symptoms in type A aortic dissections. Stroke. 2007;38(2):292–7.
Kosuge M, Uchida K, Imoto K, Hashiyama N, Ebina T, Hibi K, et al. Frequency and implication of ST-T abnormalities on hospital admission electrocardiograms in patients with type A acute aortic dissection. Am J Cardiol. 2013;112(3):424–9.
Pourafkari L, Tajlil A, Ghaffari S, Chavoshi M, Kolahdouzan K, Parvizi R, et al. Electrocardiography changes in acute aortic dissection-association with troponin leak, coronary anatomy, and prognosis. Am J Emerg Med. 2016;34(8):1431–6.
Kosuge M, Uchida K, Imoto K, Isoda S, Karube N, Ebina T, et al. Prognostic value of ST-segment elevation in lead aVR in patients with Type A acute aortic dissection. J Am Coll Cardiol. 2015;65(23):2570–1.
Hirata K, Wake M, Kyushima M, Takahashi T, Nakazato J, Mototake H, et al. Electrocardiographic changes in patients with type A acute aortic dissection. Incidence, patterns and underlying mechanisms in 159 cases. J Cardiol. 2010;56(2):147–53.
Watanabe H, Horita N, Shibata Y, Minegishi S, Ota E, Kaneko T. Diagnostic test accuracy of D-dimer for acute aortic syndrome: systematic review and meta-analysis of 22 studies with 5000 subjects. Sci Rep. 2016;6:26893.
Huang B, Yang Y, Lu H, Zhao Z, Zhang S, Hui R, et al. Impact of d-Dimer levels on admission on inhospital and long-term outcome in patients with Type A acute aortic dissection. Am J Cardiol. 2015;115(11):1595–600.
Gorla R, Erbel R, Kahlert P, Tsagakis K, Jakob H, Mahabadi AA, et al. Diagnostic role and prognostic implications of D-dimer in different classes of acute aortic syndromes. Eur Heart J Acute Cardiovasc Care. 2015;6(5):379–88.
Suzuki T, Distante A, Zizza A, Trimarchi S, Villani M, Salerno Uriarte JA, et al. Diagnosis of acute aortic dissection by D-dimer: the International Registry of Acute Aortic Dissection Substudy on Biomarkers (IRAD-Bio) experience. Circulation. 2009;119(20):2702–7.
Sodeck G, Domanovits H, Schillinger M, Janata K, Thalmann M, Ehrlich MP, et al. Pre-operative N-terminal pro-brain natriuretic peptide predicts outcome in type A aortic dissection. J Am Coll Cardiol. 2008;51(11):1092–7.
MacKnight BM, Maldonado Y, Augoustides JG, Cardenas RA, Patel PA, Ghadimi K, et al. Advances in imaging for the management of acute aortic syndromes: focus on transesophageal echocardiography and Type-A aortic dissection for the perioperative echocardiographer. J Cardiothorac Vasc Anesth. 2016;30(4):1129–41.
Hagan PG, Nienaber CA, Isselbacher EM, Bruckman D, Karavite DJ, Russman PL, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA. 2000;283(7):897–903.
Ridge CA, Litmanovich DE. Acute aortic syndromes: current status. J Thorac Imaging. 2015;30(3):193–201.
Takami Y, Tajima K, Kato W, Fujii K, Hibino M, Munakata H, et al. Can we predict the site of entry tear by computed tomography in patients with acute type a aortic dissection? Clin Cardiol. 2012;35(8):500–4.
Ciccone MM, Dentamaro I, Masi F, Carbonara S, Ricci G. Advances in the diagnosis of acute aortic syndromes: role of imaging techniques. Vasc Med. 2016;21(3):239–50.
Evangelista A, Carro A, Moral S, Teixido-Tura G, Rodriguez-Palomares JF, Cuellar H, et al. Imaging modalities for the early diagnosis of acute aortic syndrome. Nat Rev Cardiol. 2013;10(8):477–86.
Bossone E, Evangelista A, Isselbacher E, Trimarchi S, Hutchison S, Gilon D, et al. Prognostic role of transesophageal echocardiography in acute type A aortic dissection. Am Heart J. 2007;153(6):1013–20.
Bossone E, Suzuki T, Eagle KA, Weinsaft JW. Diagnosis of acute aortic syndromes : imaging and beyond. Herz. 2013;38(3):269–76.
Pare JR, Liu R, Moore CL, Sherban T, Kelleher MS Jr, Thomas S, et al. Emergency physician focused cardiac ultrasound improves diagnosis of ascending aortic dissection. Am J Emerg Med. 2016;34(3):486–92.
Hansen MS, Nogareda GJ, Hutchison SJ. Frequency of and inappropriate treatment of misdiagnosis of acute aortic dissection. Am J Cardiol. 2007;99(6):852–6.
Hirata K, Wake M, Takahashi T, Nakazato J, Yagi N, Miyagi T, et al. Clinical predictors for delayed or inappropriate initial diagnosis of Type A acute aortic dissection in the emergency room. PLoS One. 2015;10(11):e0141929.
Harris KM, Strauss CE, Eagle KA, Hirsch AT, Isselbacher EM, Tsai TT, et al. Correlates of delayed recognition and treatment of acute type A aortic dissection: the International Registry of Acute Aortic Dissection (IRAD). Circulation. 2011;124(18):1911–8.
Rapezzi C, Longhi S, Graziosi M, Biagini E, Terzi F, Cooke RM, et al. Risk factors for diagnostic delay in acute aortic dissection. Am J Cardiol. 2008;102(10):1399–406.
Souza D, Ledbetter S. Diagnostic errors in the evaluation of nontraumatic aortic emergencies. Semin Ultrasound CT MR. 2012;33(4):318–36.
Feldman M, Shah M, Elefteriades JA. Medical management of acute type A aortic dissection. Ann Thorac Cardiovasc Surg. 2009;15(5):286–93.
Bonser RS, Ranasinghe AM, Loubani M, Evans JD, Thalji NM, Bachet JE, et al. Evidence, lack of evidence, controversy, and debate in the provision and performance of the surgery of acute type A aortic dissection. J Am Coll Cardiol. 2011;58(24):2455–74.
Tolenaar JL, van Bogerijen GH, Eagle KA, Trimarchi S. Update in the management of aortic dissection. Curr Treat Options Cardiovasc Med. 2013;15(2):200–13.
Elefteriades JA, Feldman M. Acute type A aortic dissection: surgical intervention for all: CON. Cardiol Clin. 2010;28(2):325–31.
Fukuda I, Imazuru T. Intentional delay of surgery for acute type A dissection with stroke. J Thorac Cardiovasc Surg. 2003;126(1):290–1.
Tsukube T, Haraguchi T, Okada Y, Matsukawa R, Kozawa S, Ogawa K, et al. Long-term outcomes after immediate aortic repair for acute type A aortic dissection complicated by coma. J Thorac Cardiovasc Surg. 2014;148(3):1013–8; discussion 8–9.
Centofanti P, Flocco R, Ceresa F, Attisani M, La Torre M, Weltert L, et al. Is surgery always mandatory for type A aortic dissection? Ann Thorac Surg. 2006;82(5):1658–63; discussion 64.
Most H, Reinhard B, Gahl B, Englberger L, Kadner A, Weber A, et al. Is surgery in acute aortic dissection type A still contraindicated in the presence of preoperative neurological symptoms? Eur J Cardiothorac Surg. 2015;48(6):945–50; discussion 50.
Di Eusanio M, Patel HJ, Nienaber CA, Montgomery DM, Korach A, Sundt TM, et al. Patients with type A acute aortic dissection presenting with major brain injury: should we operate on them? J Thorac Cardiovasc Surg. 2013;145(3 Suppl):S213–21 e1.
Lenos A, Bougioukakis P, Irimie V, Zacher M, Diegeler A, Urbanski PP. Impact of surgical experience on outcome in surgery of acute type A aortic dissection. Eur J Cardiothorac Surg. 2015;48(3):491–6.
Grau JB, Kuschner CE, Ferrari G, Wilson SR, Brizzio ME, Zapolanski A, et al. Effects of a protocol-based management of type A aortic dissections. J Surg Res. 2015;197(2):265–9.
Knipp BS, Deeb GM, Prager RL, Williams CY, Upchurch GR Jr, Patel HJ. A contemporary analysis of outcomes for operative repair of type A aortic dissection in the United States. Surgery. 2007;142(4):524–8; discussion 8 e1.
El-Hamamsy I, Ouzounian M, Demers P, McClure S, Hassan A, Dagenais F, et al. State-of-the-Art surgical management of acute type A aortic dissection. Can J Cardiol. 2016;32(1):100–9.
Kirsch M, Soustelle C, Houel R, Hillion ML, Loisance D. Risk factor analysis for proximal and distal reoperations after surgery for acute type A aortic dissection. J Thorac Cardiovasc Surg. 2002;123(2):318–25.
Roselli EE, Loor G, He J, Rafael AE, Rajeswaran J, Houghtaling PL, et al. Distal aortic interventions after repair of ascending dissection: the argument for a more aggressive approach. J Thorac Cardiovasc Surg. 2015;149(2 Suppl):S117–24 e3.
Halstead JC, Meier M, Etz C, Spielvogel D, Bodian C, Wurm M, et al. The fate of the distal aorta after repair of acute type A aortic dissection. J Thorac Cardiovasc Surg. 2007;133(1):127–35.
Leontyev S, Haag F, Davierwala PM, Lehmkuhl L, Borger MA, Etz CD, et al. Postoperative changes in the distal residual aorta after surgery for acute Type A aortic dissection: impact of false lumen patency and size of descending aorta. Thorac Cardiovasc Surg. 2017;65(2):90–8.
Rice RD, Sandhu HK, Leake SS, Afifi RO, Azizzadeh A, Charlton-Ouw KM, et al. Is total arch replacement associated with worse outcomes during repair of acute type A aortic dissection? Ann Thorac Surg. 2015;100(6):2159–65; discussion 65–6.
Li B, Ma WG, Liu YM, Sun LZ. Is extended arch replacement justified for acute type A aortic dissection? Interact Cardiovasc Thorac Surg. 2015;20(1):120–6.
Di Eusanio M, Berretta P, Cefarelli M, Jacopo A, Murana G, Castrovinci S, et al. Total arch replacement versus more conservative management in type A acute aortic dissection. Ann Thorac Surg. 2015;100(1):88–94.
Kim JB, Chung CH, Moon DH, Ha GJ, Lee TY, Jung SH, et al. Total arch repair versus hemiarch repair in the management of acute DeBakey type I aortic dissection. Eur J Cardiothorac Surg. 2011;40(4):881–7.
Uchida N, Shibamura H, Katayama A, Shimada N, Sutoh M. Total arch replacement with an open stent graft for acute type A aortic dissection: fate of the false lumen. Eur J Cardiothorac Surg. 2009;35(1):83–8.
Zhang H, Lang X, Lu F, Song Z, Wang J, Han L, et al. Acute type A dissection without intimal tear in arch: proximal or extensive repair? J Thorac Cardiovasc Surg. 2014;147(4):1251–5.
Inoue Y, Minatoya K, Oda T, Itonaga T, Seike Y, Tanaka H, et al. Surgical outcomes for acute type A aortic dissection with aggressive primary entry resection. Eur J Cardiothorac Surg. 2016;50:567–73.
Easo J, Weigang E, Holzl PP, Horst M, Hoffmann I, Blettner M, et al. Influence of operative strategy for the aortic arch in DeBakey type I aortic dissection - analysis of the German Registry for Acute Aortic Dissection type A (GERAADA). Ann Cardiothorac Surg. 2013;2(2):175–80.
Apaydin AZ, Islamoglu F, Posacioglu H, Calkavur T, Yagdi T, Atay Y, et al. Surgical treatment of acute arch dissection. Jpn J Thorac Cardiovasc Surg. 2003;51(2):48–52.
Ohtsubo S, Itoh T, Takarabe K, Rikitake K, Furukawa K, Suda H, et al. Surgical results of hemiarch replacement for acute type A dissection. Ann Thorac Surg. 2002;74(5):S1853–6; discussion S7–63.
Pichlmaier MA, Teebken OE, Baraki H, Haverich A. The frozen elephant trunk technique. Multimed Man Cardiothorac Surg. 2007;2007(329):1–9.
Sun L, Qi R, Zhu J, Liu Y, Zheng J. Total arch replacement combined with stented elephant trunk implantation: a new “standard” therapy for type a dissection involving repair of the aortic arch? Circulation. 2011;123(9):971–8.
Shrestha M, Beckmann E, Krueger H, Fleissner F, Kaufeld T, Koigeldiyev N, et al. The elephant trunk is freezing: the Hannover experience. J Thorac Cardiovasc Surg. 2015;149(5):1286–93.
Uchida N, Katayama A, Tamura K, Sutoh M, Kuraoka M, Ishihara H. Frozen elephant trunk technique and partial remodeling for acute type A aortic dissection. Eur J Cardiothorac Surg. 2011;40(5):1066–71.
Murzi M, Tiwari KK, Farneti PA, Glauber M. Might type A acute dissection repair with the addition of a frozen elephant trunk improve long-term survival compared to standard repair? Interact Cardiovasc Thorac Surg. 2010;11(1):98–102.
Lin HH, Liao SF, Wu CF, Li PC, Li ML. Outcome of frozen elephant trunk technique for acute type A aortic dissection: as systematic review and meta-analysis. Medicine (Baltimore). 2015;94(16):e694.
Uchida N, Shibamura H, Katayama A, Shimada N, Sutoh M, Ishihara H. Operative strategy for acute type a aortic dissection: ascending aortic or hemiarch versus total arch replacement with frozen elephant trunk. Ann Thorac Surg. 2009;87(3):773–7.
Leontyev S, Borger MA, Etz CD, Moz M, Seeburger J, Bakhtiary F, et al. Experience with the conventional and frozen elephant trunk techniques: a single-centre study. Eur J Cardiothorac Surg. 2013;44(6):1076–82; discussion 83.
Yan Y, Xu L, Zhang H, Xu ZY, Ding XY, Wang SW, et al. Proximal aortic repair versus extensive aortic repair in the treatment of acute type A aortic dissection: a meta-analysis. Eur J Cardiothorac Surg. 2016;49(5):1392–401.
Ma WG, Zhang W, Wang LF, Zheng J, Ziganshin BA, Charilaou P, et al. Type A aortic dissection with arch entry tear: surgical experience in 104 patients over a 12-year period. J Thorac Cardiovasc Surg. 2016;151(6):1581–92.
Shrestha M, Fleissner F, Ius F, Koigeldiyev N, Kaufeld T, Beckmann E, et al. Total aortic arch replacement with frozen elephant trunk in acute type A aortic dissections: are we pushing the limits too far?dagger. Eur J Cardiothorac Surg. 2015;47(2):361–6; discussion 6.
Sun LZ, Qi RD, Chang Q, Zhu JM, Liu YM, Yu CT, et al. Surgery for acute type A dissection using total arch replacement combined with stented elephant trunk implantation: experience with 107 patients. J Thorac Cardiovasc Surg. 2009;138(6):1358–62.
Shi E, Gu T, Yu Y, Yu L, Wang C, Fang Q, et al. Early and midterm outcomes of hemiarch replacement combined with stented elephant trunk in the management of acute DeBakey type I aortic dissection: comparison with total arch replacement. J Thorac Cardiovasc Surg. 2014;148(5):2125–31.
Urbanski PP, Lenos A, Irimie V, Bougioukakis P, Zacher M, Diegeler A. Acute aortic dissection involving the root: operative and long-term outcome after curative proximal repair. Interact Cardiovasc Thorac Surg. 2016;22(5):620–6.
Peterss S, Dumfarth J, Rizzo JA, Bonaros N, Fang H, Tranquilli M, et al. Sparing the aortic root in acute aortic dissection type A: risk reduction and restored integrity of the untouched rootdagger. Eur J Cardiothorac Surg. 2016;50(2):232–9.
Castrovinci S, Pacini D, Di Marco L, Berretta P, Cefarelli M, Murana G, et al. Surgical management of aortic root in type A acute aortic dissection: a propensity-score analysisdagger. Eur J Cardiothorac Surg. 2016;50(2):223–9.
Beckmann E, Martens A, Alhadi FA, Ius F, Koigeldiyev N, Fleissner F, et al. Is Bentall procedure still the gold standard for acute aortic dissection with aortic root involvement? Thorac Cardiovasc Surg. 2016;64(2):116–23.
Wang Z, Greason KL, Pochettino A, Schaff HV, Suri RM, Stulak JM, et al. Long-term outcomes of survival and freedom from reoperation on the aortic root or valve after surgery for acute ascending aorta dissection. J Thorac Cardiovasc Surg. 2014;148(5):2117–22.
Di Eusanio M, Trimarchi S, Peterson MD, Myrmel T, Hughes GC, Korach A, et al. Root replacement surgery versus more conservative management during type A acute aortic dissection repair. Ann Thorac Surg. 2014;98(6):2078–84.
Subramanian S, Leontyev S, Borger MA, Trommer C, Misfeld M, Mohr FW. Valve-sparing root reconstruction does not compromise survival in acute type A aortic dissection. Ann Thorac Surg. 2012;94(4):1230–4.
Montalvo J, Razzouk A, Wang N, Bansal R, Rasi A, Hasaniya N, et al. Aortic root surgery does not increase the operative risk of acute type A aortic dissection. Am Surg. 2011;77(1):88–92.
Rylski B. To replace or not to replace: that is the question. Eur J Cardiothorac Surg. 2016;50(2):239–40.
Dell'Aquila AM, Concistre G, Gallo A, Pansini S, Piccardo A, Passerone G, et al. Fate of the preserved aortic root after treatment of acute type A aortic dissection: 23-year follow-up. J Thorac Cardiovasc Surg. 2013;146(6):1456–60.
Leshnower BG, Myung RJ, McPherson L, Chen EP. Midterm results of David V valve-sparing aortic root replacement in acute type A aortic dissection. Ann Thorac Surg. 2015;99(3):795–800; discussion -1.
Nishida H, Tabata M, Fukui T, Takanashi S. Surgical strategy and outcome for aortic root in patients undergoing repair of acute type A aortic dissection. Ann Thorac Surg. 2016;101(4):1464–9.
Rylski B, Bavaria JE, Beyersdorf F, Branchetti E, Desai ND, Milewski RK, et al. Type A aortic dissection in Marfan syndrome: extent of initial surgery determines long-term outcome. Circulation. 2014;129(13):1381–6.
Rylski B, Desai ND, Bavaria JE, Vallabhajosyula P, Moser W, Pochettino A, et al. Aortic valve morphology determines the presentation and surgical approach to acute type A aortic dissection. Ann Thorac Surg. 2014;97(6):1991–6; discussion 6–7.
Kruger T, Weigang E, Hoffmann I, Blettner M, Aebert H, Investigators G. Cerebral protection during surgery for acute aortic dissection type A: results of the German Registry for Acute Aortic Dissection Type A (GERAADA). Circulation. 2011;124(4):434–43.
Kitamura M, Hashimoto A, Akimoto T, Tagusari O, Aomi S, Koyanagi H. Operation for type A aortic dissection: introduction of retrograde cerebral perfusion. Ann Thorac Surg. 1995;59(5):1195–9.
Harrington DK, Ranasinghe AM, Shah A, Oelofse T, Bonser RS. Recommendations for haemodynamic and neurological monitoring in repair of acute type a aortic dissection. Anesthesiol Res Pract. 2011;2011:949034.
Williams ML, Ganzel BL, Slater AD, Slaughter MS, Trivedi JR, Edmonds HL, et al. Antegrade versus retrograde cerebral protection in repair of acute ascending aortic dissection. Am Surg. 2012;78(3):349–51.
Sugiura T, Imoto K, Uchida K, Minami T, Yasuda S. Comparative study of brain protection in ascending aorta replacement for acute type A aortic dissection: retrograde cerebral perfusion versus selective antegrade cerebral perfusion. Gen Thorac Cardiovasc Surg. 2012;60(10):645–8.
Etz CD, von Aspern K, da Rocha ESJ, Girrbach FF, Leontyev S, Luehr M, et al. Impact of perfusion strategy on outcome after repair for acute type a aortic dissection. Ann Thorac Surg. 2014;97(1):78–85.
Misfeld M, Leontyev S, Borger MA, Gindensperger O, Lehmann S, Legare JF, et al. What is the best strategy for brain protection in patients undergoing aortic arch surgery? A single center experience of 636 patients. Ann Thorac Surg. 2012;93(5):1502–8.
Comas GM, Leshnower BG, Halkos ME, Thourani VH, Puskas JD, Guyton RA, et al. Acute type a dissection: impact of antegrade cerebral perfusion under moderate hypothermia. Ann Thorac Surg. 2013;96(6):2135–41.
Leshnower BG, Thourani VH, Halkos ME, Sarin EL, Keeling WB, Lamias MJ, et al. Moderate versus deep hypothermia with unilateral selective antegrade cerebral perfusion for acute type A dissection. Ann Thorac Surg. 2015;100(5):1563–8; discussion 8–9.
Gong M, Ma WG, Guan XL, Wang LF, Li JC, Lan F, et al. Moderate hypothermic circulatory arrest in total arch repair for acute type A aortic dissection: clinical safety and efficacy. J Thorac Dis. 2016;8(5):925–33.
Rahimi-Barfeh A, Grothusen C, Haneya A, Schottler J, Eide AM, Erdmann M, et al. Transatrial cannulation of the left ventricle for acute type A aortic dissection: a 5-year experience. Ann Thorac Surg. 2016;101(5):1753–8.
Ren Z, Wang Z, Hu R, Wu H, Deng H, Zhou Z, et al. Which cannulation (axillary cannulation or femoral cannulation) is better for acute type A aortic dissection repair? A meta-analysis of nine clinical studies. Eur J Cardiothorac Surg. 2015;47(3):408–15.
Benedetto U, Mohamed H, Vitulli P, Petrou M. Axillary versus femoral arterial cannulation in type A acute aortic dissection: evidence from a meta-analysis of comparative studies and adjusted risk estimates. Eur J Cardiothorac Surg. 2015;48(6):953–9.
Tiwari KK, Murzi M, Bevilacqua S, Glauber M. Which cannulation (ascending aortic cannulation or peripheral arterial cannulation) is better for acute type A aortic dissection surgery? Interact Cardiovasc Thorac Surg. 2010;10(5):797–802.
Suenaga E, Sato M, Fumoto H, Kawasaki H, Koga S. Impact of transapical aortic cannulation for acute type A aortic dissection. Ann Thorac Cardiovasc Surg. 2015;21(4):382–7.
Gobolos L, Ugocsai P, Foltan M, Philipp A, Thrum A, Miskolczi S, et al. Central cannulation by Seldinger technique: a reliable method in ascending aorta and aortic arch replacement. Med Sci Monit. 2014;20:2386–93.
Inoue Y, Ueda T, Taguchi S, Kashima I, Koizumi K, Takahashi R, et al. Ascending aorta cannulation in acute type A aortic dissection. Eur J Cardiothorac Surg. 2007;31(6):976–9; discussion 9–81.
Klotz S, Heuermann K, Hanke T, Petersen M, Sievers HH. Outcome with peripheral versus central cannulation in acute Type A dissection dagger. Interact Cardiovasc Thorac Surg. 2015;20(6):749–53; discussion 54.
Matsushita A, Manabe S, Tabata M, Fukui T, Shimokawa T, Takanashi S. Efficacy and pitfalls of transapical cannulation for the repair of acute type A aortic dissection. Ann Thorac Surg. 2012;93(6):1905–9.
Suzuki T, Asai T, Matsubayashi K, Kambara A, Kinoshita T, Hiramatsu N, et al. Safety and efficacy of central cannulation through ascending aorta for type A aortic dissection. Interact Cardiovasc Thorac Surg. 2010;11(1):34–7.
Mody PS, Wang Y, Geirsson A, Kim N, Desai MM, Gupta A, et al. Trends in aortic dissection hospitalizations, interventions, and outcomes among medicare beneficiaries in the United States, 2000-2011. Circ Cardiovasc Qual Outcomes. 2014;7(6):920–8.
Zimmerman KP, Oderich G, Pochettino A, Hanson KT, Habermann EB, Bower TC, et al. Improving mortality trends for hospitalization of aortic dissection in the National Inpatient Sample. J Vasc Surg. 2016;64(3):606–615.e1.
Russo CF, Mariscalco G, Colli A, Sante P, Nicolini F, Miceli A, et al. Italian multicentre study on type A acute aortic dissection: a 33-year follow-updagger. Eur J Cardiothorac Surg. 2016;49(1):125–31.
Conzelmann LO, Weigang E, Mehlhorn U, Abugameh A, Hoffmann I, Blettner M, et al. Mortality in patients with acute aortic dissection type A: analysis of pre- and intraoperative risk factors from the German Registry for Acute Aortic Dissection Type A (GERAADA). Eur J Cardiothorac Surg. 2016;49(2):e44–52.
Goda M, Imoto K, Suzuki S, Uchida K, Yanagi H, Yasuda S, et al. Risk analysis for hospital mortality in patients with acute type a aortic dissection. Ann Thorac Surg. 2010;90(4):1246–50.
Teman NR, Peterson MD, Russo MJ, Ehrlich MP, Myrmel T, Upchurch GR Jr, et al. Outcomes of patients presenting with acute type A aortic dissection in the setting of prior cardiac surgery: an analysis from the International Registry of Acute Aortic Dissection. Circulation. 2013;128(11 Suppl 1):S180–5.
Rylski B, Desai ND, Bavaria JE, Moser W, Vallabhajosyula P, Pochettino A, et al. Type A aortic dissection after previous cardiac surgery: results of an integrated surgical approach. Ann Thorac Surg. 2014;97(5):1582–8; discussion 8–9.
Estrera AL, Miller CC, Kaneko T, Lee TY, Walkes JC, Kaiser LR, et al. Outcomes of acute type a aortic dissection after previous cardiac surgery. Ann Thorac Surg. 2010;89(5):1467–74.
Deeb GM, Patel HJ, Williams DM. Treatment for malperfusion syndrome in acute type A and B aortic dissection: a long-term analysis. J Thorac Cardiovasc Surg. 2010;140(6 Suppl):S98–S100; discussion S42-S46
Pacini D, Leone A, Belotti LM, Fortuna D, Gabbieri D, Zussa C, et al. Acute type A aortic dissection: significance of multiorgan malperfusion. Eur J Cardiothorac Surg. 2013;43(4):820–6.
Girdauskas E, Kuntze T, Borger MA, Falk V, Mohr FW. Surgical risk of preoperative malperfusion in acute type A aortic dissection. J Thorac Cardiovasc Surg. 2009;138(6):1363–9.
Patel HJ, Williams DM, Dasika NL, Suzuki Y, Deeb GM. Operative delay for peripheral malperfusion syndrome in acute type A aortic dissection: a long-term analysis. J Thorac Cardiovasc Surg. 2008;135(6):1288–95; discussion 95–6.
Girardi LN, Krieger KH, Lee LY, Mack CA, Tortolani AJ, Isom OW. Management strategies for type A dissection complicated by peripheral vascular malperfusion. Ann Thorac Surg. 2004;77(4):1309–14; discussion 14.
Czerny M, Schoenhoff F, Etz C, Englberger L, Khaladj N, Zierer A, et al. The impact of pre-operative malperfusion on outcome in acute type A aortic dissection: results from the GERAADA registry. J Am Coll Cardiol. 2015;65(24):2628–35.
Olsson C, Franco-Cereceda A. Impact of organ failure and major complications on outcome in acute Type A aortic dissection. Scand Cardiovasc J. 2013;47(6):352–8.
Geirsson A, Szeto WY, Pochettino A, McGarvey ML, Keane MG, Woo YJ, et al. Significance of malperfusion syndromes prior to contemporary surgical repair for acute type A dissection: outcomes and need for additional revascularizations. Eur J Cardiothorac Surg. 2007;32(2):255–62.
Immer FF, Grobety V, Lauten A, Carrel TP. Does malperfusion syndrome affect early and mid-term outcome in patients suffering from acute type A aortic dissection? Interact Cardiovasc Thorac Surg. 2006;5(2):187–90.
Di Eusanio M, Trimarchi S, Patel HJ, Hutchison S, Suzuki T, Peterson MD, et al. Clinical presentation, management, and short-term outcome of patients with type A acute dissection complicated by mesenteric malperfusion: observations from the International Registry of Acute Aortic Dissection. J Thorac Cardiovasc Surg. 2013;145(2):385–90 e1.
Meriggi F, Alloni A, Gramigna P, Tramelli P, Vigano M. Acute aortic dissection with intestinal ischemia: what to do first. Ann Thorac Cardiovasc Surg. 2011;17(6):631–3.
Firstenberg MS, Sai-Sudhakar CB, Sirak JH, Crestanello JA, Sun B. Intestinal ischemia complicating ascending aortic dissection: first things first. Ann Thorac Surg. 2007;84(2):e8–9.
Toda R, Moriyama Y, Masuda H, Iguro Y, Yamaoka A, Taira A. Organ malperfusion in acute aortic dissection. Jpn J Thorac Cardiovasc Surg. 2000;48(9):545–50.
Shiiya N, Matsuzaki K, Kunihara T, Murashita T, Matsui Y. Management of vital organ malperfusion in acute aortic dissection: proposal of a mechanism-specific approach. Gen Thorac Cardiovasc Surg. 2007;55(3):85–90.
Eren E, Toker ME, Tuncer A, Keles C, Erdogan HB, Anasiz H, et al. Surgical management of coronary malperfusion due to type a aortic dissection. J Card Surg. 2007;22(1):2–6.
Kawahito K, Adachi H, Murata S, Yamaguchi A, Ino T. Coronary malperfusion due to type A aortic dissection: mechanism and surgical management. Ann Thorac Surg. 2003;76(5):1471–6; discussion 6.
Schoenrath F, Laber R, Maralushaj M, Henzi D, Caliskan EI, Seifert B, et al. Survival, neurologic injury, and kidney function after surgery for acute type A aortic dissection. Thorac Cardiovasc Surg. 2016;64(2):100–7.
Stamou SC, Hagberg RC, Khabbaz KR, Stiegel MR, Reames MK, Skipper E, et al. Is advanced age a contraindication for emergent repair of acute type A aortic dissection? Interact Cardiovasc Thorac Surg. 2010;10(4):539–44.
Suenaga E, Sato M, Fumoto H. Ascending aortic replacement for acute type A aortic dissection in octogenarians. Gen Thorac Cardiovasc Surg. 2016;64(3):138–43.
Kondoh H, Satoh H, Daimon T, Tauchi Y, Yamamoto J, Abe K, et al. Outcomes of limited proximal aortic replacement for type A aortic dissection in octogenarians. J Thorac Cardiovasc Surg. 2016;152(2):439–46.
El-Sayed Ahmad A, Papadopoulos N, Detho F, Srndic E, Risteski P, Moritz A, et al. Surgical repair for acute type A aortic dissection in octogenarians. Ann Thorac Surg. 2015;99(2):547–51.
Berndt R, Haneya A, Jussli-Melchers J, Tautorat I, Schmidt K, Rahimi A, et al. Outcome after surgery for acute aortic dissection type A in the elderly: a single-center experience. Thorac Cardiovasc Surg. 2015;63(2):113–9.
Rylski B, Hoffmann I, Beyersdorf F, Suedkamp M, Siepe M, Nitsch B, et al. Acute aortic dissection type A: age-related management and outcomes reported in the German Registry for Acute Aortic Dissection Type A (GERAADA) of over 2000 patients. Ann Surg. 2014;259(3):598–604.
Piccardo A, Regesta T, Pansini S, Concistre G, Dell’Aquila A, Scarano F, et al. Should octogenarians be denied access to surgery for acute type A aortic dissection? J Cardiovasc Surg. 2009;50(2):205–12.
Rylski B, Suedkamp M, Beyersdorf F, Nitsch B, Hoffmann I, Blettner M, et al. Outcome after surgery for acute aortic dissection type A in patients over 70 years: data analysis from the German Registry for Acute Aortic Dissection Type A (GERAADA). Eur J Cardiothorac Surg. 2011;40(2):435–40.
Hata M, Sezai A, Yoshitake I, Wakui S, Minami K, Shiono M. Midterm outcomes of rapid, minimally invasive resection of acute type A aortic dissection in octogenarians. Ann Thorac Surg. 2010;89(6):1860–4.
Hata M, Suzuki M, Sezai A, Niino T, Unosawa S, Furukawa N, et al. Less invasive quick replacement for octogenarians with type A acute aortic dissection. J Thorac Cardiovasc Surg. 2008;136(2):489–93.
Boening A, Karck M, Conzelmann LO, Easo J, Kruger T, Rylski B, et al. German registry for acute aortic dissection type A: structure, results, and future perspectives. Thorac Cardiovasc Surg. 2017;65(2):77–84.
Zindovic I, Sjogren J, Bjursten H, Danielsson E, Ingemansson R, Nozohoor S. Impact of hemodynamic instability and organ malperfusion in elderly surgical patients treated for acute type A aortic dissection. J Card Surg. 2015;30(11):822–9.
Biancari F, Vasques F, Benenati V, Juvonen T. Contemporary results after surgical repair of type A aortic dissection in patients aged 80 years and older: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2011;40(5):1058–63.
Piccardo A, Regesta T, Zannis K, Gariboldi V, Pansini S, Tapia M, et al. Outcomes after surgical treatment for type A acute aortic dissection in octogenarians: a multicenter study. Ann Thorac Surg. 2009;88(2):491–7.
Komatsu K, Takano T, Terasaki T, Wada Y, Seto T, Fukui D, et al. Surgical outcomes of acute type A aortic dissection in elderly patients. Ann Thorac Surg. 2014;97(5):1576–81.
Tang GH, Malekan R, Yu CJ, Kai M, Lansman SL, Spielvogel D. Surgery for acute type A aortic dissection in octogenarians is justified. J Thorac Cardiovasc Surg. 2013;145(3 Suppl):S186–90.
Kilic A, Tang R, Whitson BA, Sirak JH, Sai-Sudhakar CB, Crestanello J, et al. Outcomes in the current surgical era following operative repair of acute Type A aortic dissection in the elderly: a single-institutional experience. Interact Cardiovasc Thorac Surg. 2013;17(1):104–9.
Trimarchi S, Eagle KA, Nienaber CA, Rampoldi V, Jonker FH, De Vincentiis C, et al. Role of age in acute type A aortic dissection outcome: report from the International Registry of Acute Aortic Dissection (IRAD). J Thorac Cardiovasc Surg. 2010;140(4):784–9.
Malvindi PG, Modi A, Miskolczi S, Kaarne M, Barlow C, Ohri SK, et al. Acute type A aortic dissection repair in elderly patients. Eur J Cardiothorac Surg. 2015;48(5):664–70; discussion 71.
Vanhuyse F, Maureira P, Laurent N, Lekehal M, Grandmougain D, Villemot JP. Surgery for acute type A aortic dissection in octogenarians. J Card Surg. 2012;27(1):65–9.
Woo YJ, Kozin ED. Repair of type A aortic dissection in nonagenarian. Asian Cardiovasc Thorac Ann. 2010;18(2):183–4.
Wu IH, Yu HY, Liu CH, Chen YS, Wang SS, Lin FY. Is old age a contraindication for surgical treatment in acute aortic dissection? A demographic study of national database registry in Taiwan. J Card Surg. 2008;23(2):133–9.
Shrestha M, Khaladj N, Haverich A, Hagl C. Is treatment of acute type A aortic dissection in septuagenarians justifiable? Asian Cardiovasc Thorac Ann. 2008;16(1):33–6.
Di Eusanio M, Schepens MA, Morshuis WJ, Di Bartolomeo R, Pacini D, Di Eusanio G, et al. Surgery for acute type A aortic dissection: the effect of antegrade selective cerebral perfusion on the early outcome of elderly patients. Ital Heart J. 2005;6(4):335–40.
Sorabella RA, Wu YS, Bader A, Kim MJ, Smith CR, Takayama H, et al. Aortic root replacement in octogenarians offers acceptable perioperative and late outcomes. Ann Thorac Surg. 2016;101(3):967–72.
Niclauss L, Delay D, von Segesser LK. Type A dissection in young patients. Interact Cardiovasc Thorac Surg. 2011;12(2):194–8.
Januzzi JL, Isselbacher EM, Fattori R, Cooper JV, Smith DE, Fang J, et al. Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD). J Am Coll Cardiol. 2004;43(4):665–9.
Bossone E, Pyeritz RE, O'Gara P, Harris KM, Braverman AC, Pape L, et al. Acute aortic dissection in blacks: insights from the International Registry of Acute Aortic Dissection. Am J Med. 2013;126(10):909–15.
Nienaber CA, Fattori R, Mehta RH, Richartz BM, Evangelista A, Petzsch M, et al. Gender-related differences in acute aortic dissection. Circulation. 2004;109(24):3014–21.
Fukui T, Tabata M, Morita S, Takanashi S. Gender differences in patients undergoing surgery for acute type A aortic dissection. J Thorac Cardiovasc Surg. 2015;150(3):581–7 e1.
Conway BD, Stamou SC, Kouchoukos NT, Lobdell KW, Hagberg RC. Effects of gender on outcomes and survival following repair of acute type A aortic dissection. Int J Angiol. 2015;24(2):93–8.
Maitusong B, Sun HP, Xielifu D, Mahemuti M, Ma X, Liu F, et al. Sex-related differences between patients with symptomatic acute aortic dissection. Medicine (Baltimore). 2016;95(11):e3100.
Speir A. Gender differences in patients undergoing surgery for acute type A aortic dissection: Is there really a glass ceiling? J Thorac Cardiovasc Surg. 2015;150(3):587–8.
Rylski B, Desjardins B, Moser W, Bavaria JE, Milewski RK. Gender-related changes in aortic geometry throughout life. Eur J Cardiothorac Surg. 2014;45(5):805–11.
Rajagopalan S, Nwazota N, Chandrasekhar S. Outcomes in pregnant women with acute aortic dissections: a review of the literature from 2003 to 2013. Int J Obstet Anesth. 2014;23(4):348–56.
Ch'ng SL, Cochrane AD, Goldstein J, Smith JA. Stanford type a aortic dissection in pregnancy: a diagnostic and management challenge. Heart Lung Circ. 2013;22(1):12–8.
Regeer MV, Versteegh MI, Klautz RJ, Schalij MJ, Bax JJ, Marsan NA, et al. Comparison of left ventricular volume and ejection fraction and frequency and extent of aortic regurgitation after operative repair of type A aortic dissection among three different surgical techniques. Am J Cardiol. 2016;117(7):1167–72.
Nunez-Gil IJ, Bautista D, Cerrato E, Salinas P, Varbella F, Omede P, et al. Incidence, management, and immediate- and long-term outcomes after iatrogenic aortic dissection during diagnostic or interventional coronary procedures. Circulation. 2015;131(24):2114–9.
Rylski B, Hoffmann I, Beyersdorf F, Suedkamp M, Siepe M, Nitsch B, et al. Iatrogenic acute aortic dissection type A: insight from the German Registry for Acute Aortic Dissection Type A (GERAADA). Eur J Cardiothorac Surg. 2013;44(2):353–9; discussion 9.
Leontyev S, Borger MA, Legare JF, Merk D, Hahn J, Seeburger J, et al. Iatrogenic type A aortic dissection during cardiac procedures: early and late outcome in 48 patients. Eur J Cardiothorac Surg. 2012;41(3):641–6.
Hwang HY, Jeong DS, Kim KH, Kim KB, Ahn H. Iatrogenic type A aortic dissection during cardiac surgery. Interact Cardiovasc Thorac Surg. 2010;10(6):896–9.
Melby SJ, Zierer A, Damiano RJ Jr, Moon MR. Importance of blood pressure control after repair of acute type a aortic dissection: 25-year follow-up in 252 patients. J Clin Hypertens (Greenwich). 2013;15(1):63–8.
Concistre G, Casali G, Santaniello E, Montalto A, Fiorani B, Dell'Aquila A, et al. Reoperation after surgical correction of acute type A aortic dissection: risk factor analysis. Ann Thorac Surg. 2012;93(2):450–5.
Kimura N, Tanaka M, Kawahito K, Yamaguchi A, Ino T, Adachi H. Influence of patent false lumen on long-term outcome after surgery for acute type A aortic dissection. J Thorac Cardiovasc Surg. 2008;136(5):1160–6, 6 e1–3.
Zierer A, Voeller RK, Hill KE, Kouchoukos NT, Damiano RJ Jr, Moon MR. Aortic enlargement and late reoperation after repair of acute type A aortic dissection. Ann Thorac Surg. 2007;84(2):479–86; discussion 86–7.
Chaddha A, Kline-Rogers E, Braverman AC, Erickson SR, Jackson EA, Franklin BA, et al. Survivors of aortic dissection: activity, mental health, and sexual function. Clin Cardiol. 2015;38(11):652–9.
Chiu KW, Lakshminarayan R, Ettles DF. Acute aortic syndrome: CT findings. Clin Radiol. 2013;68(7):741–8.
Uchida K, Imoto K, Takahashi M, Suzuki S, Isoda S, Sugiyama M, et al. Pathologic characteristics and surgical indications of superacute type A intramural hematoma. Ann Thorac Surg. 2005;79(5):1518–21.
Alomari IB, Hamirani YS, Madera G, Tabe C, Akhtar N, Raizada V. Aortic intramural hematoma and its complications. Circulation. 2014;129(6):711–6.
Song JK. Update in acute aortic syndrome: intramural hematoma and incomplete dissection as new disease entities. J Cardiol. 2014;64(3):153–61.
Harris KM, Braverman AC, Eagle KA, Woznicki EM, Pyeritz RE, Myrmel T, et al. Acute aortic intramural hematoma: an analysis from the International Registry of Acute Aortic Dissection. Circulation. 2012;126(11 Suppl 1):S91–6.
Ho HH, Cheung CW, Jim MH, Miu KM, Siu CW, Lam YM, et al. Type A aortic intramural hematoma: clinical features and outcomes in Chinese patients. Clin Cardiol. 2011;34(3):E1–5.
Matsushita A, Fukui T, Tabata M, Sato Y, Takanashi S. Preoperative characteristics and surgical outcomes of acute intramural hematoma involving the ascending aorta: a propensity score-matched analysis. J Thorac Cardiovasc Surg. 2016;151(2):351–8.
Uchida K, Imoto K, Karube N, Minami T, Cho T, Goda M, et al. Intramural haematoma should be referred to as thrombosed-type aortic dissection. Eur J Cardiothorac Surg. 2013;44(2):366–9; discussion 9.
Estrera AL, Sandhu HK, Leake SS, Charlton-Ouw KM, Afifi RO, Miller CC 3rd, et al. Early and late outcomes of acute type A aortic dissection with intramural hematoma. J Thorac Cardiovasc Surg. 2015;149(1):137–42.
Song JK. Aortic intramural hematoma: aspects of pathogenesis 2011. Herz. 2011;36(6):488–97.
Chao CP, Walker TG, Kalva SP. Natural history and CT appearances of aortic intramural hematoma. Radiographics. 2009;29(3):791–804.
Choi YJ, Son JW, Lee SH, Kim U, Shin DG, Kim YJ, et al. Treatment patterns and their outcomes of acute aortic intramural hematoma in real world: multicenter registry for aortic intramural hematoma. BMC Cardiovasc Disord. 2014;14:103.
Kan CB, Chang RY, Chang JP. Optimal initial treatment and clinical outcome of type A aortic intramural hematoma: a clinical review. Eur J Cardiothorac Surg. 2008;33(6):1002–6.
Attia R, Young C, Fallouh HB, Scarci M. In patients with acute aortic intramural haematoma is open surgical repair superior to conservative management? Interact Cardiovasc Thorac Surg. 2009;9(5):868–71.
Hata M, Hata H, Sezai A, Yoshitake I, Wakui S, Shiono M. Optimal treatment strategy for type A acute aortic dissection with intramural hematoma. J Thorac Cardiovasc Surg. 2014;147(1):307–11.
Kitai T, Kaji S, Yamamuro A, Tani T, Tamita K, Kinoshita M, et al. Clinical outcomes of medical therapy and timely operation in initially diagnosed type a aortic intramural hematoma: a 20-year experience. Circulation. 2009;120(11 Suppl):S292–8.
Estrera A, Miller C 3rd, Lee TY, De Rango P, Abdullah S, Walkes JC, et al. Acute type A intramural hematoma: analysis of current management strategy. Circulation. 2009;120(11 Suppl):S287–91.
Lansman SL, Saunders PC, Malekan R, Spielvogel D. Acute aortic syndrome. J Thorac Cardiovasc Surg. 2010;140(6 Suppl):S92–7; discussion S142-S6
Song JK, Yim JH, Ahn JM, Kim DH, Kang JW, Lee TY, et al. Outcomes of patients with acute type a aortic intramural hematoma. Circulation. 2009;120(21):2046–52.
Watanabe S, Hanyu M, Arai Y, Nagasawa A. Initial medical treatment for acute type a intramural hematoma and aortic dissection. Ann Thorac Surg. 2013;96(6):2142–6.
Nathan DP, Boonn W, Lai E, Wang GJ, Desai N, Woo EY, et al. Presentation, complications, and natural history of penetrating atherosclerotic ulcer disease. J Vasc Surg. 2012;55(1):10–5.
Stanson AW, Kazmier FJ, Hollier LH, Edwards WD, Pairolero PC, Sheedy PF, et al. Penetrating atherosclerotic ulcers of the thoracic aorta: natural history and clinicopathologic correlations. Ann Vasc Surg. 1986;1(1):15–23.
Wada H, Sakata N, Tashiro T. Clinicopathological study on penetrating atherosclerotic ulcers and aortic dissection: distinct pattern of development of initial event. Heart Vessels. 2016;31(11):1855–61.
Chou AS, Ziganshin BA, Charilaou P, Tranquilli M, Rizzo JA, Elefteriades JA. Long-term behavior of aortic intramural hematomas and penetrating ulcers. J Thorac Cardiovasc Surg. 2016;151(2):361–72. 73 e1.
Bischoff MS, Geisbusch P, Peters AS, Hyhlik-Durr A, Bockler D. Penetrating aortic ulcer: defining risks and therapeutic strategies. Herz. 2011;36(6):498–504.
Stamou SC, Kouchoukos NT. Penetrating ulcer of the ascending aorta. J Am Coll Cardiol. 2011;57(11):1327.
Agrifoglio M, Cappai A, Filippi N, Alamanni F. Penetrating atherosclerotic ulcer of the ascending aorta: the role of computed tomography scan. J Cardiovasc Med (Hagerstown). 2011;12(9):671–2.
Sundt TM. Intramural hematoma and penetrating atherosclerotic ulcer of the aorta. Ann Thorac Surg. 2007;83(2):S835–41; discussion S46–50.
Jain D, Gehl HB, Katus HA, Richardt G. Penetrating atherosclerotic ulcer of the ascending aorta: a delayed complication of coronary artery bypass surgery--a case report. Angiology. 2003;54(2):251–5.
Coady MA, Rizzo JA, Hammond GL, Pierce JG, Kopf GS, Elefteriades JA. Penetrating ulcer of the thoracic aorta: what is it? How do we recognize it? How do we manage it? J Vasc Surg. 1998;27(6):1006–15; discussion 15–6.
Baikoussis NG, Apostolakis EE. Penetrating atherosclerotic ulcer of the thoracic aorta: diagnosis and treatment. Hell J Cardiol. 2010;51(2):153–7.
Kimura N, et al. Utility of the Penn classification in predicting outcomes of surgery for acute type A aortic dissection. Am J Cardiol. 2014;113(4):724–30.
Sobczyk D, Nycz K. Feasibility and accuracy of bedside transthoracic echocardiography in diagnosis of acute proximal aortic dissection. Cardiovasc Ultrasound. 2015 Mar 25;13:15.
Dougenis D. Repair of acute type A aortic dissection: moving towards a more aggressive approach but keeping the old gold standards. Eur J Cardiothorac Surg. 2016;49:131–3.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pinnelas, R., Vaishnava, P., Eagle, K.A. (2019). Ascending Aortic Dissection, Penetrating Aortic Ulcer, and Intramural Hematoma. In: Dieter, R., Dieter Jr., R., Dieter III, R. (eds) Diseases of the Aorta . Springer, Cham. https://doi.org/10.1007/978-3-030-11322-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-11322-3_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11321-6
Online ISBN: 978-3-030-11322-3
eBook Packages: MedicineMedicine (R0)